Case Report
Published on 14 Feb 2025
A case report of a MODY6 patient coexistence with Charcot-Marie-Toothe 1A syndrome
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1502783
- 2,604 views
- 2 citations
18 articles related to "Oral Hypoglycemic Agents"
Articles
Review
Published on 04 Jun 2021
Sodium-Glucose Co-transporter-2 Inhibitors and Nephroprotection in Diabetic Patients: More Than a Challenge
in Nephrology
Frontiers in Medicine
doi 10.3389/fmed.2021.654557
- 12,281 views
- 27 citations
Mini Review
Published on 22 Jan 2025
Recent advances in pancreatic α-cell transdifferentiation for diabetes therapy
in Alloimmunity and Transplantation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1551372
- 7,920 views
- 6 citations
Original Research
Published on 17 Jun 2022
Sodium Glucose Cotransporter-2 Inhibitor Protects Against Diabetic Neuropathy and Nephropathy in Modestly Controlled Type 2 Diabetes: Follow-Up Study
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2022.864332
- 5,615 views
- 19 citations
Case Report
Published on 10 Aug 2022
Case report: SARS-CoV-2 infection as a trigger for diabetic ketoacidosis and newly detected pancreatic autoantibodies
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2022.983206
- 3,778 views
- 3 citations
Case Report
Published on 02 Sep 2020
Exogenous Insulin Injection-Induced Stiff-Person Syndrome in a Patient With Latent Autoimmune Diabetes: A Case Report and Literature Review
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2020.00594
- 9,275 views
- 6 citations
Case Report
Accepted on 12 Feb 2026
Case report: A case of diabetes mellitus and pneumonitis induced by envafolimab treatment in small cell lung cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Original Research
Published on 18 Aug 2025
Re-starting or initiating guideline-recommended hypoglycemic agents for patients admitted with hyperglycemic crisis
in Intensive Care Medicine and Anesthesiology
Frontiers in Medicine
doi 10.3389/fmed.2025.1485357
- 2,532 views
Original Research
Published on 11 Oct 2022
Antidiabetic effects of Brugmansia aurea leaf extract by modulating the glucose levels, insulin resistance, and oxidative stress mechanism
in Food Chemistry
Frontiers in Nutrition
doi 10.3389/fnut.2022.1005341
- 4,423 views
- 7 citations
Systematic Review
Published on 02 Jul 2025
Long-term effects of SGLT2 inhibitors on arrhythmias: a systematic review and meta-analysis
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1558367
- 3,224 views
- 1 citation
Systematic Review
Published on 16 Nov 2022
Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1015045
- 70,275 views
- 70 citations
Clinical Trial
Published on 23 Sep 2025
Imeglimin-based therapies improve glycemic control and reduce mitochondrial stress in type 2 diabetes: a prospective cohort study
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1639046
- 3,154 views
- 1 citation
Systematic Review
Published on 30 Jan 2026
Effects of intermittent fasting on HbA1c and weight in insulin versus oral hypoglycemic therapy-treated patients with type 2 diabetes mellitus: a systematic review and meta-analysis
in Nutrition and Metabolism
Frontiers in Nutrition
doi 10.3389/fnut.2026.1699384
- 2,380 views
Original Research
Published on 14 Nov 2024
Predicting hypoglycemia in elderly inpatients with type 2 diabetes: the ADOCHBIU model
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1366184
- 3,545 views
- 3 citations
Original Research
Published on 26 Feb 2019
Modulation of Autophagy Influences the Function and Survival of Human Pancreatic Beta Cells Under Endoplasmic Reticulum Stress Conditions and in Type 2 Diabetes
in Endocrinology of Aging
Frontiers in Endocrinology
doi 10.3389/fendo.2019.00052
- 9,480 views
- 84 citations
Original Research
Published on 12 Oct 2021
Dapagliflozin, as Add-on Therapy in Type 2 Diabetes Patients, Is Associated With a Reduction in Albuminuria and Serum Transaminase Levels
in Diabetes Therapies
Frontiers in Clinical Diabetes and Healthcare
doi 10.3389/fcdhc.2021.733693
- 2,946 views
- 2 citations